Targeted alpha-particle therapy

This page covers all Targeted alpha-particle therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CD47.

Targets

CD47

Phase 2 pipeline (1)

• 131-I-TM-601 · TransMolecular · Oncology
  131-I-TM-601 is a targeted alpha-particle therapy that selectively targets and destroys cancer cells.